Table 2. Quality Scores using AGREE II Instruments for included CPGs on RA.
| Agree II domains | ACR | BSR | BSR &BHP | Eular | Forestieret al. | Gossecet al. | Hurkmanet al. | NICE | OttawaPanel | RACGP | SIGN | (mn ±SD) |
| [30] | [31] | [32] | [33] | [34] | [35] | [36] | [37] | [38]–[42] | [43] | [44] | ||
| Domain 1 | 17% | 83% | 89% | 17% | 86% | 89% | 47% | 75% | 97% | 97% | 81% | 70.4%±42% |
| Domain 2 | 25% | 75% | 75% | 36% | 67% | 64% | 86% | 89% | 72% | 86% | 94% | 70.6%±26% |
| Domain 3 | 11% | 34% | 32% | 44% | 71% | 58% | 69% | 52% | 65% | 84% | 55% | 52.4%±23% |
| Domain 4 | 11% | 83% | 67% | 14% | 100% | 39% | 94% | 39% | 61% | 100% | 97% | 64.0%±28% |
| Domain 5 | 17% | 50% | 8% | 0% | 46% | 0% | 4% | 17% | 10% | 17% | 35% | 18.5%±35% |
| Domain 6 | 38% | 38% | 46% | 0% | 50% | 21% | 8% | 92% | 42% | 33% | 54% | 38.3%±23% |
| Quality of CPGs (mn±SD) | 3.5±0.5 | 4.5±0.71 | 4.5±0.71 | 4±1.41 | 5.5±0.5 | 5±0 | 5±0 | 4±0 | 5.5±0.71 | 6.5±0.71 | 5±1.41 | 4.8±0.61 |
| Assessed by | PR & LB | PR &LB | PR & LB | PR & LB | PR & LB | PR & LB | PR & LB | PR & LB | PR & KTA | PR & LB | PR & LB | PR & LB |
ACR: American College of Rheumatology, BSR: British society of rheumatology; EULAR: The European League against rheumatism; NICE: National Institute for health and Clinical Excellence; SIGN: Scottish Intercollegiate Guidelines Network; 
: mean; SD: standard deviation.